ArticleBiomedicines2023

Polypharmacy, Potentially Inappropriate Medications, and Drug-to-Drug Interactions in Patients with Chronic Myeloproliferative Neoplasms.

Ivan Krečak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.